网站主页
化工产品目录
医药中间体
原料药中间体
鲁索利替尼中间体
(2S,3S)-2,3-bis(benzoyloxy)butanedioic acid; (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]prop
![(2S,3S)-2,3-bis(benzoyloxy)butanedioic acid; (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]prop](/SupplyImg/2023-08-29/202308291811239163709.png)
(2S,3S)-2,3-bis(benzoyloxy)butanedioic acid; (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]prop
Ruxolitinib intermediate
询价
1KG
起订
10KG
起订
上海 更新日期：2025-11-21
产品详情:
- 中文名称：
- (2S,3S)-2,3-bis(benzoyloxy)butanedioic acid; (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]prop
- 英文名称：
- Ruxolitinib intermediate
- CAS号：
- 1236033-04-7
- 纯度规格：
- 99%+
- 产品类别：
- 黄金产品
公司简介
Founded by a group of veterans from the US biopharmaceutical industry in 2010, P&T is now a leading Shanghai-based CRO company providing drug discovery and development services worldwide
| 成立日期 | (12年) |
| 注册资本 | 200万人民币 |
| 员工人数 | 50-100人 |
| 年营业额 | ￥ 5000万-1亿 |
| 经营模式 | 工厂,定制 |
| 主营行业 | 医药中间体,原料药 |
![(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate;](https://img.chemicalbook.com/SupplyImg1/2024-09-02/Large/202409021251134734754.jpg)
![(2R,3R,4S,5R)-2-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-4-(benzyloxy)-5-((benzyloxy)methyl)-5-(hydroxymethyl)tetrahydrofuran-3-yl acetate](https://img.chemicalbook.com/SupplyImg1/2025-07-03/Large/202507031459252702359.jpg)
